Michele Robertson is the senior vice president and chief compliance officer at Mallinckrodt Pharmaceuticals. She is responsible for the global compliance function and commercial legal function, and is a member of Mallinckrodt’s senior leadership team.
Ms. Robertson joined Mallinckrodt through its Ikaria, Inc. acquisition in April of 2015, and has since held roles of increasing responsibility within the legal function. During her time at Ikaria, she provided legal support across all functions of the organization. Previously, Ms. Robertson held various roles at Schering Plough Pharmaceuticals, where she provided legal support to the company’s clinical programs in its research institute.
Ms. Robertson graduated cum laude with a bachelor’s degree in journalism from Rutgers College in New Brunswick and holds a Juris Doctor degree from Rutgers School of Law, Camden.